| abstract |
The present invention relates to the preparation of a medicament wherein the main aspect of action is oxytoxin and / or vasopressin receptor inhibition in a non-pregnant uterus of a mammal that improves uterine solubility in fertilized egg transplantation, the antagonist of oxytoxin, oxytoxin and vasopressin, vasopressin Antagonists, pharmaceutically acceptable salts thereof, or combinations thereof with other drugs. The present invention also relates to the use of these substances in the manufacture of a medicament for modulating uterine contractile activity in artificial insemination. |